Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

Ana-Maria Orbai, MD, FACR, MHS: Guselkumab Improves PROMIS-29 Scores in Patients …,

In this phase 3 trial, the primary outcome is American College of Rheumatology (ACR) 20, which is quite standard for psoriatic arthritis clinical …, In this phase 3 trial, the primary outcome is American College of Rheumatology (ACR) 20, which is quite standard for psoriatic arthritis clinical …, Read More

Scroll to Top